Skip to main content

Find Clinical Trials

Home
Conditions
Prostatic Neoplasms

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,739 public trials 967 recruiting studies

Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

NCT01656161

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Paarl Medical Centre Paarl, Cape Town, Western Cape, South Africa

Vergelegen Medi-Clinic Somerset West, Cape Town, South Africa

Department of Urology, Tygerberg Hospital Tygerberg, Cape Town, South Africa

JCM Bahlmann George, Eastern Cape, South Africa

View Trial Details

Completed

Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient

NCT02338700

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations: Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China

View Trial Details

Completed

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

NCT00818480

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +26 more
Locations: Institute for Drug Development San Antonio, Texas, United States

South Texas Accelerated San Antonio, Texas, United States

Huntsman Cancer Hospital Salt Lake City, Utah, United States

View Trial Details

Completed

Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

NCT02437539

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +20 more
Locations: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

NCT00777959

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Not specified

View Trial Details

Completed

A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer

NCT01215526

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Jeroen Bosch Ziekenhuis, locatie Carolus 's-Hertogenbosch, Netherlands

Flevoziekenhuis Almere Stad, Netherlands

Bovenij Ziekenhuis Amsterdam, Netherlands

Wilhelminaziekenhuis Assen, Netherlands

View all 47 locations

View Trial Details

Completed

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer

NCT01897207

Conditions: Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +8 more
Locations: Not specified

View Trial Details

Completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

NCT01621425

Conditions: Body Weight, Breast Cancer, Breast Diseases, +16 more
Locations: Deventer Hospital Deventer, Netherlands

Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

NCT00514267

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: San Antonio, Texas, United States

View Trial Details

Completed

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

NCT00817739

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations: Not specified

View Trial Details